139 related articles for article (PubMed ID: 22612513)
1. Mucinous cystadenocarcinoma of the breast with a basal-like immunophenotype.
Deng Y; Xue D; Wang X; Xu S; Ao Q; Hu Z; Wang G
Pathol Int; 2012 Jun; 62(6):429-32. PubMed ID: 22612513
[TBL] [Abstract][Full Text] [Related]
2. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma.
Chen WY; Chen CS; Chen HC; Hung YJ; Chu JS
Pathol Int; 2004 Oct; 54(10):781-6. PubMed ID: 15482568
[TBL] [Abstract][Full Text] [Related]
3. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings.
Sentani K; Tashiro T; Uraoka N; Aosaki Y; Yano S; Takaeko F; Yasui W
Diagn Cytopathol; 2012 Jul; 40(7):624-8. PubMed ID: 21472867
[TBL] [Abstract][Full Text] [Related]
4. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma.
Lee SH; Chaung CR
Pathol Int; 2008 Sep; 58(9):601-5. PubMed ID: 18801076
[TBL] [Abstract][Full Text] [Related]
5. Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported.
Petersson F; Pang B; Thamboo TP; Putti TC
Hum Pathol; 2010 Jun; 41(6):910-3. PubMed ID: 20338619
[TBL] [Abstract][Full Text] [Related]
6. Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity.
Koufopoulos N; Goudeli C; Syrios J; Filopoulos E; Khaldi L
Rare Tumors; 2017 Oct; 9(3):7016. PubMed ID: 29081926
[TBL] [Abstract][Full Text] [Related]
7. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases.
Gwin K; Wheeler DT; Bossuyt V; Tavassoli FA
Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292
[TBL] [Abstract][Full Text] [Related]
8. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
10. Mixed primary mucinous cystadenocarcinoma and invasive ductal carcinoma of the breast: a case report and literature review.
Zuo C; Xie J
Transl Cancer Res; 2022 Dec; 11(12):4455-4464. PubMed ID: 36644191
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
12. Mucinous cystadenocarcinoma of the breast.
Koenig C; Tavassoli FA
Am J Surg Pathol; 1998 Jun; 22(6):698-703. PubMed ID: 9630176
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic carcinoma occurring in association with a mucinous cystic neoplasm of the pancreas.
Lane RB; Sangüeza OP
Arch Pathol Lab Med; 1997 May; 121(5):533-5. PubMed ID: 9167613
[TBL] [Abstract][Full Text] [Related]
14. Mammary synchronous mucinous cystadenocarcinoma and columnar cell mucinous carcinoma: a case report.
Sun M; Su S; Liu Q; Li Q; Wang K
Int J Clin Exp Pathol; 2020; 13(9):2381-2386. PubMed ID: 33042347
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
[TBL] [Abstract][Full Text] [Related]
16. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
17. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases.
Ro JY; Sneige N; Sahin AA; Silva EG; del Junco GW; Ayala AG
Arch Pathol Lab Med; 1991 Feb; 115(2):137-40. PubMed ID: 1847035
[TBL] [Abstract][Full Text] [Related]
18. Identification of a basal-like subtype of breast ductal carcinoma in situ.
Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
20. Mucinous carcinoma of the skin: evaluation of lymphatic invasion with D2-40.
Paradela S; Castiñeiras I; Cuevas J; Almagro M; del Pozo J; Fonseca E
Am J Dermatopathol; 2008 Oct; 30(5):504-8. PubMed ID: 18806501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
